Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Sargramostim/Zidovudine	NCIT_C15480
Androgen Therapy	NCIT_C15482	[Administration of male hormones to produce a clinical effect.]
Progestin Therapy	NCIT_C15484	[The use of progestogens in the treatment of any disease or disorder.]
Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma	NCIT_C7054	[Lymphocyte-rich classic Hodgkin lymphoma occurring in childhood.]
Neurotoxicity Attenuation	NCIT_C15485
Precursor Lymphoid Neoplasm	NCIT_C7055	[A neoplasm of immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage. Neoplasms involving the bone marrow and the peripheral blood are called precursor lymphoblastic leukemias or acute lymphoblastic leukemias. Neoplasms involving primarily lymph nodes or extranodal sites are called lymphoblastic lymphomas. -- 2003]
Prostaglandin Inhibition	NCIT_C15486
Hypercalcemia Therapy	NCIT_C15487	[Any care or treatment provided for the resolution of an abnormally high blood calcium concentration.]
Disease, Disorder or Finding	NCIT_C7057	[A condition that is relevant to human neoplasms and non-neoplastic disorders. This includes observations, test results, history and other concepts relevant to the characterization of human pathologic conditions.]
Drug Modulation	NCIT_C15488
Meningioma by Morphology	NCIT_C7050
Releasing Hormone Agonist Therapy	NCIT_C15489	[The use of releasing hormone agonists to bind to specific receptors and ultimately downregulate the activity of its specific hormone.]
Meningioma by Site	NCIT_C7051
Meningioma	NCIT_C3230	[A generally slow growing tumor attached to the dura mater. It is composed of neoplastic meningothelial (arachnoidal) cells. It typically occurs in adults, often women and it has a wide range of histopathological appearances. Of the various subtypes, meningothelial, fibrous and transitional meningiomas are the most common. Most meningiomas are WHO grade I tumors, and some are WHO grade II or III tumors. Most subtypes share a common clinical behavior, although some subtypes are more likely to recur and follow a more aggressive clinical course. (Adapted from WHO)]
NF2 Gene Inactivation	NCIT_C36686
Loss of Chromosome 1p	NCIT_C36501	[A cytogenetic abnormality that refers to the loss of all or part of the short arm of chromosome 1 (1p). It has been described in gliomas, meningiomas, neuroblastomas, hepatocellular carcinomas, breast carcinomas, acinar prostate adenocarcinomas, pancreatic carcinomas, and adrenal gland adenomas.]
Gain of Chromosome 17q	NCIT_C36484	[A cytogenetic abnormality that refers to the duplication of all or part of the long arm of chromosome 17.]
Gain of Chromosome 9q	NCIT_C36483
Gain of Chromosome 12q	NCIT_C36441	[A chromosomal aberration where there are 3 copies of the long arm of chromosome 12. This aberration is associated with 12q duplication syndrome.]
Gain of Chromosome 20q	NCIT_C36480